XML 80 R20.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Licensing Agreements | 12 Months Ended
--- | ---
Apr. 30, 2014
Licensing Agreements [Abstract] |
Licensing Agreements Disclosure [Text Block] | Note 6. Licensing Agreements In February 2010, the Company entered into an exclusive option agreement with a Canadian company. The option agreement granted the Company the exclusive right to review Irinophore C, a nanoparticle drug compound, for the treatment of various forms of cancer, including melanoma, prostate, breast, and lung cancer. On June 26th, 2014 the Company terminated its exclusive option agreement.

X
- Details
Name: | csbr_LicensingAgreementsAbstract
Namespace Prefix: | csbr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure related to several different licensing agreements. + References No definition available. + Details
Name: | csbr_LicensingAgreementsDisclosureTextBlock
Namespace Prefix: | csbr_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration